Breakdown | ||||
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.71B | 9.24B | 9.76B | 9.74B | 9.55B | Gross Profit |
1.45B | 1.50B | 1.37B | 1.66B | 1.43B | EBIT |
402.28M | 482.41M | 357.80M | 552.58M | 349.14M | EBITDA |
651.08M | 647.30M | 665.54M | 830.86M | 726.80M | Net Income Common Stockholders |
128.08M | 126.17M | 71.08M | 179.17M | 180.16M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
2.15B | 1.88B | 956.72M | 1.91B | 2.14B | Total Assets |
13.30B | 13.71B | 13.78B | 13.45B | 13.64B | Total Debt |
5.55B | 6.18B | 6.08B | 5.95B | 6.91B | Net Debt |
3.40B | 4.30B | 5.13B | 4.04B | 4.77B | Total Liabilities |
8.52B | 9.03B | 9.19B | 8.88B | 9.12B | Stockholders Equity |
4.78B | 4.68B | 4.60B | 4.57B | 4.53B |
Cash Flow | Free Cash Flow | |||
1.05B | 900.60M | -924.38M | 856.60M | 267.90M | Operating Cash Flow |
1.26B | 1.18B | -694.99M | 1.11B | 588.18M | Investing Cash Flow |
-288.57M | -213.17M | -230.97M | -248.94M | -222.80M | Financing Cash Flow |
-713.97M | -43.94M | -29.48M | -1.08B | -118.39M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | ¥5.78B | 6.41 | 3.40% | 16.98% | 16.26% | ||
76 Outperform | ¥3.14B | 8.74 | 2.93% | 10.31% | 77.52% | ||
70 Neutral | ¥3.00B | 19.86 | 2.24% | -0.35% | -39.08% | ||
67 Neutral | ¥4.02B | 18.30 | 1.00% | 11.25% | 58.54% | ||
61 Neutral | ¥4.37B | 33.33 | 1.31% | 5.14% | 1.96% | ||
51 Neutral | $2.04B | -1.15 | -21.24% | 3.95% | 2.91% | -30.44% | |
46 Neutral | ¥4.51B | 521.41 | 2.87% | -3.17% | -21.99% |